Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera by unknown
ANTIBODY-DEPENDENT CELL-MEDIATED ANTIBACTERIAL 
ACTIVITY OF  HUMAN MONONUCLEAR  CELLS 
I. K  Lymphocytes and Monocytes are Effective against 
Meningococci in Cooperation with Human Immune Sera 
BY GEORGE H. LOWELL, LYNETTE F.  SMITH, MALCOLM S. ARTENSTEIN,* 
GEOFFREY S.  NASH,:~ AND RICHARD P.  MAcDERMOTT, Jr.~ 
From the Departments  of Bacterial Diseases,  Immunology,  and Gastroenterology, the  Walter Reed Army 
Institute of Research,  Washington,  D. C. 20012 
It has been well demonstrated that lymphocytes can, in the absence of complement, 
kill  a  variety  of  mammalian  and  fowl  target  cells  in  cooperation  with  specific 
antitarget cell antibodies in vitro (1, 2). Recent experiments have suggested that this 
immune process, generally referred to as antibody-dependent cell-mediated cytotox- 
icity  (ADCC), 1  may  be  an  important  host  immune  defense  mechanism  against 
infectious agents (3). Specifically, virus-infected cells (4), parasites (5, 6), and bacterial 
membrane-coated erythrocytes  (7)  have  been  used  as  targets  in  ADCC  reactions. 
Consequently, we considered it possible that lymphocytes might also have antibody- 
dependent  antibacterial  capabilities.  Whereas  the  ability  of  monocytes  (8)  and 
polymorphonuclear  leukocytes  (PMN)  (8,  9)  to  phagocytize  and  kill  bacteria  in 
cooperation with opsonizing antibody and complement (10)  is well known, lympho- 
cyte-mediated antibacterial activity has not previously been well explored. 
We have investigated the in vitro cell-mediated antibacterial capability of human 
peripheral blood lymphocytes and monocytes in the absence of complement. Viable 
group C  meningococci  (Mgc)  were used  as targets in  a  modified  form of an  assay 
previously used to measure the bactericidal activity of monocytes (8,  11). Because the 
major human effector lymphocyte in ADCC has been identified  as a  K  cell  (which 
possesses readily identifiable Fc receptors but  lacks easily detectable surface immu- 
noglobulin)  (2,  12-14), we also tested isolated K-, T-, and B-lymphocyte subpopula- 
tions in our assay. Our data indicate that in the presence of human immune serum 
known to contain  high levels of antimeningococcal antibody  (Ab),  lymphocytes (as 
well as monocytes) can be effector cells mediating antibody-dependent cell-mediated 
(ADC)  antibacterial activity. Furthermore, K  cells, but not T  or B cells, possess this 
capability. In the absence of Ab, we could not demonstrate antibacterial activity by 
any cell type tested. 
* Dr. Malcolm S. Artenstein died on March 9, 1976. His untimely passing was a personal and scientific 
loss deeply felt by the authors. 
:]: Present address, Division of Gastroenterology,  Washington University Medical School, St. Louis, Mo. 
63110. 
1 Abbreviations used in  this paper: Ab, human  antiserum from individuals immunized with group C 
meningococcal polysaccharide; ABI, antibacterial index; ADC, antibody-dependent cell-mediated; ADCC, 
antibody-dependent cellular cytotoxicity; Csss, group C meningococcal polysaccharide; Mgc, group C 
meningococci; PMN, polymorphonuclear leukocytes; WBC, human peripheral blood leukocytes. 
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Materials  and  Methods 
Bacteria.  Pathogenic group C  serotype II Mgc (Neisseria meningitidis strain 138-1) originally 
isolated from spinal fluid were stored and cultured for use as previously described (15). Just 
before the antibacterial assay, the organisms were diluted in Mueller-Hinton broth to appro- 
priate concentrations and maintained at 4°C. 
Antisera.  Postvaccination antisera from normal adults who had antibody rises after immu- 
nization with group C meningococcal polysaccharide (Csss) (16) were used at dilutions ranging 
from 1:5 to 1:1,280.  0.1 ml of immune serum typically contained enough anti-Csss antibody to 
bind 5,200 ng of Csss measured in the radioactive-binding assay developed by Brandt et al. 
(17).  Also,  the  Ab  used  were  effective  in  a  standard,  complement  dependent  (cell-free) 
bactericidal assay (15) at titres up to 1/640-1/1,280. All antisera were heat inactivated at 56°C 
for 1,~ h  before use to destroy all complement and noncomplement  heat-labile opsonins. To 
adsorb anti-Mgc antibodies, 4 ml of diluted antisera were rotated end-over-end for 2 h at 4°C 
in  13  X  75-mm  test  tubes  containing  an  overnight  Petri  plate  growth  of  PBS-washed 
homologous Mgc (strain 138-1) or heterologous (group B, serotype 6, strain M990) meningococci. 
Bacteria were removed by centrifugation and the adsorbed sera sterilized by passage through 
a  0.45-#m  millipore membrane.  Adequacy of adsorption of anti-Mgc antibodies from  the 
antiserum was tested using a standard bactericidal assay (15). 
Preparation of Enriched Populations of Lymphocytes and Monocytes.  Peripheral blood was obtained 
from either normal adults or from adults who  had been successfully immunized with Csss. 
Mononuclear cells were separated from either heparinized or defibrinated blood by dextran 
sedimentation followed by Ficoll-Hypaque (Pharmacia  Fine Chemicals, Div.  of Pharmacia 
Inc., Piscataway, N.J.) density eentrifugation as previously described (18). These mononuclear 
cells were incubated overnight at 37°C  in 5% CO2 humidified atmosphere in  75 cm  2 plastic 
Falcon  flasks  (Falcon  Labware,  Div.  of  Becton,  Dickinson  &  Co.,  Oxnard,  Calif.)  at  a 
concentration of 2  X  108 cells/ml. Incubation was performed in culture media (RPMI-1640 
with 2.5% Hepes buffer and 1-glutamine brought to pH 7.4 plus 20% heat-inactivated fetal calf 
serum).  During  this  incubation,  contaminating  PMN  underwent  autolysis  (2,  19)  and  the 
majority of monocytes adhered to the plastic flasks (2-4). Mononuclear cells that did not adhere 
to plastic were washed three times in culture media and then used in the antibacterial assay. 
Mononuclear cells that  did adhere to plastic after the overnight incubation were bathed in 
serum-free Hanks' Balanced Salt Solution without Ca  ++ and Mg  ++ for 2 h  at 4°C, dislodged 
from the flasks by vigorous shaking (and, when necessary, use of rubber policemen), washed, 
and then used without further purification. 
Preparation of Purified Populations  of Lymphocytes.  Nonadherent mononuclear cells were further 
depleted of monocytes by passage over a nylon wool column as previously described (4, 12, 14). 
Preparation of Purified Subpopulations of Lymphocytes.  Mononuclear cells were fractionated into 
lymphocyte subpopulations consisting of T, B, and Null (K) cells using the methods described 
by Chess et al. (20)  and modified as described in part by Nelson and MacDermott  (21)  (see 
diagram in Fig. 1). 
Identification of Leukocyte (WBC)  Populations.  Lymphocytes, monocytes, and  PMN  in each 
cell population were identified by four previously described methods:  (a)  Wright's stain,  (b) 
methylene  blue  wet  mount  morphology,  (c)  0.81-#m  latex  particle  phagocytosis,  and  (d) 
Kaplow's myeloperoxidase (22)  or a-naphthyl butyrate nonspecific esterase  (23)  stains. The 
initial Ficoll-Hypaque-separated mononuclear cells consisted of 77.5  +  7% lymphocytes, 21 
+  8%  monocytes,  and  1.5  +  0.5%  PMN.  The  percentage of lymphocytes in  each  of the 
populations used  in  this  study was  as  follows:  nonadherent  mononuclear  cells, 95  _  3%; 
purified lymphocytes, 99.5  +  0.5%;  adherent mononuclear cells, 13  _+  8%. The remainder of 
the cells in each of these populations were morphologically and  histochemically monocytes 
although a somewhat lower percentage of these cells were actively phagocytic. There were no 
PMN in any mononuclear cell population used. No latex phagocytizing cells were seen in any 
purified lymphocyte preparation. 
The purified T-lymphocyte population did not bear surface immunoglobulin (<0.5%)  and 
76% formed overnight E rosettes. Isolated B lymphocytes did not form E rosettes (<0.5%) but 
did bear surface immunoglobulin (86-96%). Null cells did not bear surface immunoglobulin 
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FIG.  t.  Isolation ofT, B, and Null (K) lymphoeytes. We note that the investigators  who orginally 
described this technique have referred to non-surface-immunoglobulin-bearing, non-E-rosette form- 
ing, Fc-receptor-bearing lymphocytes as Null cells. We have therefore used  the terms "Null cell" 
and "K cell" interchangeably in this paper. 
Cell-Mediated Antibacterial Assay.  A  modification of the bactericidal assay reported by Steig- 
bigel et al. (8) and Kretsehmer et al. (11)  which measures leukocyte-mediated interference with 
bacterial growth was used to evaluate the antibacterial  activity of nonadherent  mononuclear 
cells, purified lymphocytes, and enriched populations of monocytes. The test was performed in 
12  ×  75-ram sterile glass or plastic tubes into which 0.1 ml of the bacterial suspension  (with 2- 
6  ×  10  z  Mgc)  were deposited  along  with  0.1  ml  of culture-media-diluted  Ab.  The  tubes, 
maintained  at 4°C, were then centrifuged at  2,400 g  for  10  min; 0.2 ml of one of the above 
WBC populations  (containing 0.2-300  ×  104 WBC) was then added to these tubes. The final 
volume  of each  tube  was  brought  to  0.5  ml  with  cold  culture  media  and  the  tubes  were 
recentrifuged at  250 g  at 4°C for  10 rain to maximize contact between WBC and bacteria as 
recommended by Territo and Cline (24). Control tubes containing the same concentrations of 
culture media, Ab, and bacteria, but without leukocytes, were treated in a manner identical to 
and in parallel with the experimental tubes. In experiments designed to conserve reagents and 
cells,  the  entire  assay  was  performed  in  a  total  vol  of 0.1  ml.  When  this  was  the  case,  all 
quantities  in the test  tubes were reduced  by one-fifth of that  described above so that  proper 
concentrations could be maintained. To determine the number of bacteria added to the tubes 
at  the  start  of each  experiment,  20-p.l  aliquots  were  taken  from  sonicated  and  resuspended 
representative tubes and plated as described below. The test incubation was then performed at 
37°C in 5% CO2 humidified atmosphere for times varying from 5 to  180  (usually 45-60)  min. 
The tubes  were then  returned  to 4°C  and  sonicated  for  15  s  in a  cup horn  adaptor  (model 
431A) at a  setting of 5 with a  model 350 sonicator (Heat Systems-Ultrasonics, Inc., Plainview, 
N.  Y.).  Sonication, as recommended  by Steigbigel et al.  (8),  causes release and  dispersion of 
WBC-associated  bacteria and  prevents clumping which might otherwise result  in falsely low 
colony counts.  Microscope examination of sonicated  suspensions  showed  that  at  this setting, 
leukocytes  were  selectively  lysed  to  the  extent  that  even  membrane  fragments  were  not 
discernible.  The  Mgc,  in contrast,  were not  killed as  determined  by comparative  plating of 
samples  before  and  after  sonication.  Alter  sonication,  tubes  were  vigorously vortexed,  and 
replicate or triplicate 20-~1 aliquots from each tube were plated on Mueller-Hinton agar and 
incubated  at  37°C in 5% CO2. The following day, the number of colonies formed  from each 
aliquot was determined. 
Calculation  of Antibacterial Activity.  To compare the effects of nonadherent  mononuclear cells, 
lymphocytes,  and  monocytes on  Mgc,  the data  are expressed  by the  following antibacterial 
index (ABI): ABI  --  100-(100)  (No. of viable bacteria in suspensions  of bacteria plus WBC)/ 
No. of viable bacteria  in suspensions  of bacteria  without  cells at  the same time period.  This 
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of Mgc cultured for the same time period in the same media only without effector cells, was 
previously used  by  Steigbigel  et  al.  (8)  and  Kretschmer et  al.  (11) as  a  measure  of the 
bactericidal  activity of monocytes. We employed this  index to determine the  antibacterial 
activity of monocytes and lymphocytes because it corrects for day-to-day variation in bacterial 
growth as well as any facilitatory or inhibitory influence of the incubation media (including 
Ab) on meningoeoceal viability. 
Results 
ADC  Antibacterial  Activity  of  Nonadherent  Mononuclear  Cells  and  Purified 
Lymphocytes.  The kinetics of ADC antibacterial activity mediated by either nonad- 
herent  mononuclear cells (which contained  5% monocytes) or purified lymphocytes 
(contaminated with 0.5% monocytes) indicate that effector cell activity was minimal 
before  15 min and tended to peak after 45 rain of test incubation  at 37°C  (Fig.  2a 
and b). 
Effect  of Leukocyte~Bacteria Ratio on ADC Antibacterial Activity.  As the leukocyte-to- 
bacteria ratio increased from 150/1  to 800/1, the ABI induced by either nonadherent 
mononuclear cells or purified lymphocytes increased concomitantly (Fig. 3 a). These 
data  demonstrate  that  passage of nonadherent  mononuclear  cells over nylon  wool 
reduces  effector capacity 25-30%  relative  to the  antibacterial  activities of the cells 
before nylon wool passage. 
ADC Antibacterial Activity  of Enriched Populations of Monocytes.  As shown in Fig.  3 b, 
at ratios of 30/1,  120/1,  and 400/1,  monocyte-mediated antibacterial  activity aver- 
aged 35, 68, and 94%, respectively. At ratios < 16/1, however, no significant antibac- 
terial  activity  could  be  detected.  Because  purified  lymphocyte  populations  were 
contaminated  with  0.5%  monocytes,  even  at  purified  lymphocyte/bacteria  ratios 
which elicited maximum antibacterial activity (800/1),  the monocyte/bacteria ratio 
was only 4/1.  Consequently,  it is highly unlikely that monocytes contributed  to the 
antibacterial  activity mediated by our population  of purified lymphocytes. Nonad- 
herent mononuclear cells, in.contrast, with 5% monocyte contamination, did contain 
enough monocytes to account for some of the antibacterial activity mediated by this 
cell population.  For example, when using a  nonadherent  mononuclear cell/bacteria 
ratio of 300/1,  an  average ABI of 64%  was found  (Fig.  3a);  the  monocytes in  this 
population  could  have  caused  an  ABI  of  17%  (i.e.  26%  of the  total)  because  the 
monocyte/bacteria ratio was 16/1  (Fig. 3 b). By this method of calculation, monocytes 
could  have contributed  from  26  to  43%  of the  antibacterial  activity  mediated  by 
nonadherent mononuclear cells, with lymphocytes effecting the remainder. 
ADC Antibacterial Activity of Purified Lymphocyte Subpopulations.  To determine which 
lymphocyte subpopulations were effective in our ADC antibacterial system, purified 
B, T, and K  cells were compared with simultaneously run unseparated lymphocytes 
(containing T, B, and K  cells) and monocytes. The results of seven such experiments, 
shown  in  Table  I,  demonstrate  that  K  cells  are  the  only  lymphocytes which  are 
effector cells in our ADC antibacterial system. The antibacterial activity of purified 
T and B cells was negligible. Moreover, the antibody-dependent antibacterial capacity 
of K  cells was found to be comparable to that of monocytes. 
Effect  of Prior In  Vivo Immunization  on  Cell-Mediated  Antibacterial  Activity.  Neither 
nonadherent  mononuclear cells nor purified lymphocytes could exhibit any antibac- 
terial activity independently  (without Ab) even when cells from immunized individ- 
uals were used  (data not shown).  In addition,  enhancement  was not detected when LOWELL,  SMITH,  ARTENSTEIN,  NASH,  AND  MacDERMOTT,  Jr.  131 
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FIG. 2.  Kinetics  of ADC antibacterial activity. (A), Nonadherent mononuclear cells; (B), purified 
lymphocytes. Each point represents the mean  :t:  SEM of three values. Numbers in parentheses 
represent antibacterial indices calculated by the formula shown in Materials and Methods. Antise- 
rum, used at a  dilution of 1/160,  was constant 0-  -  -0,  leukocyte/bacteria  ratio was 400/1; 
~------~,  leukocyte/bacteria ratio was 800/1. 
the ADC  antibacterial  capacity  of nonadherent  mononuclear cells  from immunized 
individuals  (72  +  4%)  was compared to that  of nonimmunized  persons' cells  (76  + 
10%).  Similarly,  ABI  elicited  by purified  lymphocytes  of immunized  persons  (63  + 
18%) and nonimmunized individuals  (53  ±  14%) were not different from one another. 
Effect of Altered Physiologic Conditions-on ADC Antibacterial  Activity.  The  inability  of 
mononuclear  cells  to  mediate  ADC  antibacterial  activity  under  altered  physiologic 
conditions  was determined  by two methods:  (a)  No cell  population  could  elicit  any 
significant  antibacterial  activity  when  the entire  test  was  performed  at  4°C  (Table 
II).  (b)  When  mononuclear  cell  populations  were  pretreated  at  46°C  for  15-30  rain 
before  their  use in our standard  assay  (run  at  37°C),  their  ability  to  mediate  ADC 
antibacterial  activity was essentially  abolished  (Table II). Cell  viability, as measured 
by trypan blue exclusion, was not altered by either heat pretreatment  or maintenance 
at 4°C. 
Effect of Ab Concentration on ADC Antibacterial Activity.  The concentration of immune 
sera  which  elicited  optimal  nonadherent  mononuclear  cell-mediated  (Fig.  4)  or 
purified lymphocyte-mediated  (not shown) antibacterial  activity was generally  1/160. 
For most immune sera, significant  ABI could still  be detected  using serum dilutions 
up to  1/640 or  1/1,280.  In contrast, when  normal adult  sera were used, the optimal 
serum  dilution  was usually  1/10  and significant  antibacterial  activity  was generally 
not  present  at  dilutions  >1/80  (not  shown).  When  no  serum  was  present,  the 
antibacterial  index was invariably insignificant.  Fig. 4 also depicts a prozone phenom- 
enon of decreased antibacterial  activity frequently found when supra-optimal concen- 
trations of Ab were used. 
Effect of Adsorption of Specific Antibody from Antisera on the Ability of Sera to Induce Cell- 
Mediated Antibacterial Activity.  Adsorption of antisera with homologous Mgc reduced 
purified  lymphocyte-mediated  antibacterial  activity  from  51  ±  7%  to  0  ±  3%. 
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Fla.  3.  Effect  of leukocyte/bacteria ratio on ADO antibacterial activity. (A), Nonadherent mono- 
nuclear  cells and  purified  lymphocytes;  (B), enriched  populations  of monocytes. Each  point 
represents the mean  ±  SEM of three to eight experiments. Antiserum, used at a dilution of 1/160, 
was constant. Antibacterial indices were calculated by the formula shown in Materials and Methods. 
9  --+  10%, thus indicating that all functional anti-138-I meningococcal antibodies had 
been  removed.  When  heterologous  meningococci  (strains  M990)  were  used  in  the 
adsorption,  both  cell-mediated  and  (cell-free)  ADC  antibacterial  activity  were  re- 
tained  (ABI equalled  67  --+  9%  and  98  --+  2%,  respectively).  Identical  results  were 
obtained using nonadherent  mononuclear cells. 
Discussion 
The data presented in this study demonstrate that normal human peripheral blood 
lymphocytes  (specifically,  K  cells)  have  the  capacity  (as  do  monocytes)  for  ADC 
antibacterial  activity against  Mgc in cooperation with human heat-inactivated  anti- 
Csss immune serum. Lymphocyte-mediated immunity to infectious agents has previ- 
ously been demonstrated using parasites  (5, 6), virus-infected cells (4,  13), or bacterial 
membrane-coated  erythrocytes  (7)  as  targets  in  ADCC  assays.  Our  study,  using 
replicating meningococci as targets extends the antibody-dependent effector capacity 
of K  lymphocytes to bacteria. 
In  previously  described  ADCC  systems,  target  cell  lysis  has  been  measured  by 
release of radiolabeled  material  from damaged target cells. Because in our system we 
measure  the number of viable target  bacteria  by their ability to form colonies after 
overnight  culture  on  agar,  the  mechanism  of lymphocyte-mediated  antibacterial 
activity may be different from that of classically described ADCC. Nevertheless,  our 
ADC antibacterial  system is similar to ADCC in a  number of aspects as follows:  (a) 
The major lymphocytic effector cell in both systems is a  K  cell  (12-14).  (b)  Altering LOWELL, SMITH, ARTENSTEIN, NASH, AND  MacDERMOTT, Jr. 
TABLE I 
Comparison of ADC Antibacterial Activity of Purified Lymphocyte 
Subpopulations and Monocytes 
Cell type 
Antibacterial index* 
WBC/bacteria  ratio. 
400/1  100/1 
Lymphocytes (T, B, and K)  43 +  14  31  ±  6 
Bcells  ll  ±  4  18 ±  6 
Tcells  6 ±  6  12 ±  6 
K cells  67 '±  18  59 ±  8 
Monocytes  83 ±  10  53 ±  17 
* Antibacterial index was calculated as described in Materials and Methods. 
133 
physiologic conditions by either preheating the effector cells at 46°C (25) or perform- 
ing the entire  assay at  4°C  (25,  26)  abrogates  both  ADCC and  ADC antibacterial 
activity.  (c)  Neither  in  vivo nor in  vitro  immunization  is  necessary  for effector cell 
activity  of either  type.  Moreover,  cells  from  immunized  persons  do  not  exhibit 
enhanced activity compared to cells from nonimmunized  individuals.  Using ShigeUa 
flexneri  2a  as  targets,  MacDermott  et  al. 2 have  similarly  found  that  the  antibody- 
dependent  antibacterial  activity  of  cells  from  individuals  actively  infected  with 
shigellae was not different from that of uninfected persons' cells.  (d) As in all ADCC 
systems,  immune  specificity  is  totally  dependent  on the  effect  of specific  antitarget 
cell  antibodies;  indeed,  the  "prozone"  phenomenon  of decreased  activity  in  the 
presence of supra-optimal amounts of antibody has also been described in ADCC (1). 
(e) Scornik has shown that although measurement of release of radiolabeled material 
from damaged cells may not be detectable  for many hours, the critical  lytic event in 
ADCC can occur from 10 to 15 min after initiation of effector and target cell contact 
(26).  Similarly,  although we measure  the ability of viable bacteria  to form colonies 
after  18 h, ADC antibacterial  activity can be demonstrated  only when effector cells 
and target bacteria are together for at least  15 min. 
These similarities,  however, do not prove that  the ADC antibacterial  mechanism 
that we have described is identical to that of ADCC. One of the hallmarks of ADCC 
is  that  effector  cells  exert  their  cytotoxicity  extracellularly.  While  it  is  relatively 
straightforward  to determine  that target erythrocytes or nucleated cells are extracel- 
lular  to  effector  cells,  this  distinction  is  more  complex  when  the  target  cells  are 
bacteria.  Specifically, without electron microscope studies,  it is difficult to determine 
whether  bacteria  are  in  or  on  effector  cells.  Although  our  purified  lymphocyte 
populations did not phagocytize 0.81-~m latex particles, because certain lymphocytes 
may acquire increased capacities for endocytosis after in vitro incubation (27), it may 
be premature,  at  present,  to assume that even our purified  lymphocyte populations 
effect  their  antibacterial  action  via an  extracellular  mechanism.  Similarly,  because 
monocytes are capable of both ADCC (28)  and phagocytosis (8), we do speculate  at 
this time as to the mechanism whereby monocytes are effective in our system. 
2 MacDermott, R. P.,Jr., G. H. Lowell, P. L. Summers, M. Bertovich, G. Nash, A. A. Reeder, and S. B. 
Formal. 1979. Antibody-dependent cell-mediated antibacterial  activity of human mononuclear cells. III. 
Anti-shigella activity of lymphocytes, monocytes and granulocytes. Submitted for publication. 134  ANTIBACTERIAL ACTIVITY OF LYMPHOCYTES  AND MONOCYTES 
TABLE II 
Effect of Altered Physiologic  Conditions on ADC Antibacterial  Activity 
Cell type 
Antibacterial index* 
Assay run at 
Regular assay  4o C 
WBC pre-incubated 
at 46°C for 15-30 
min before use in reg- 
ular assay 
Nonadherent  mononuclear  61  +  5  5 +  4  12 +  9 
cells:[: 
Purified lymphocytes*  50 4- 5  9 4- 8  17 4- 6 
Monocytes§  70 4-  10  13 4- 7  18 +  4 
* Antibacterial index was calculated as described in Materials and Methods. 
:]: Leukocyte/bacteria ratio was 500/1. 
§ Monocyte/bacteria ratio was 200/1. 
We estimated the antibacterial contribution of the 5% monocytes in our nonadher- 
ent mononuclear cell population to be -25-36%  (see two methods of calculation in 
Results section). The percentage of K  cells among peripheral blood lymphocytes has 
been shown to average ~14%  (14, 29). By adding the 5% monocytes to these figures, 
it  can  be  seen  that  19%  of the  nonadherent  mononuclear  cells  have  effector  cell 
potential. It follows that although monocytes constitute only 5% of the total number 
of nonadherent mononuclear cells, they represent ~26%  (5/19) of the total number of 
effector cells (K cells plus monocytes) in this population. It is therefore not surprising 
that  the  antibacterial  activity generated  by nonadherent  cells reflects activity me- 
diated by both monocytes and K  l~¢mphocytes. 
Although monocytes have been  reported to be bactericidal at monocyte/bacteria 
ratios substantially lower than ours  (8), it is probable that  the absence of 10%  fresh 
serum as a  complement source in our test necessitated our use of more effector cells. 
Indeed, as shown by Steigbigel et al. (8) heat inactivation ofsera (as performed in our 
experiments) reduces the bactericidal capacity of human monocytes for gram negative 
bacteria by >90%. 
Immune specificity in our system is dependent solely upon the presence of antibodies 
which  are  directed against  the  target  bacteria.  Thus,  all antibacterial activity was 
eliminated when immune sera were adsorbed with homologous (but not heterologous) 
Mgc.  Moreover,  recent  data  from  our  laboratory indicate  that  IgG  purified  from 
human  immune serum is indeed effective in our system.  3 The critical role of specific 
antibodies in lymphocyte and monocyte-mediated antibacterial activity against Mgc 
is not surprising because susceptibility to meningococcal disease has been correlated 
in humans with the absence of antibody-mediated bactericidal activity (30). Further- 
more,  immunization  of humans  with  Csss results in  (a)  protection against  group  C 
meningococcal  disease  (31)  and  (b)  the  development  of antibodies  which  can  be 
bactericidal in cooperation with either complement  (16)  or human  peripheral blood 
PMN  (9).  Our  demonstration  in  this  study  that  human  Csss-immune  sera  can 
Lowell, G. H., L. F. Smith, J.  M. Griffiss, B. L. Brandt,  and R.  P. MacDermott.  1979. Antibody- 
dependent cell-mediated antibacterial activity of human mononuclear cells. II. Antimeningococcal activity 
of IgG,  IgM, and  IgA purified  from  human  convalescent and postimmunization  sera.  Submitted for 
publication. LOWELL,  SMITH,  ARTENSTEIN,  NASH,  AND  MacDERMOTT,  .lr.  135 
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F1o.  4.  Effect of antiserum dilution on antibody-dependent nonadherent mononuclear cell-me- 
diated antibacterial activity. Each point represents the mean  :1:  SEM of three experiments. The 
leukocyte/bacteria ratio, 400/1, was constant. Antibacterial indices were calculated as described in 
Materials and Methods. 
cooperate with lymphocytes and  monocytes in  the absence of complement extends 
the mechanism by which acquired anti-Mgc antibodies can be effectively antibacte- 
rial. 
It is difficult to determine to what degree and in which physiological setting each 
of the above antibacterial mechanisms contribute to host immune defense. Because 
lymphocyte- and monocyte-mediated ADC antibacterial activity occurs in the absence 
of complement, this mechanism may be important in the elimination of bacteria from 
those areas relatively deficient in physiologically active complement such as cerebro- 
spinal  fluid  (32)  and  mucous membrane secretions (33).  Indeed, respiratory mono- 
nuclear cells have  already been  shown  to  mediate secretory IgG-  (and  to a  lesser 
extent,  IgA-)  dependent  complement-independent  antibacterial  activity  (34).  An 
appreciation  of the  role  of ADC  antibacterial  activity  in  acquired  and  natural 
immunity to various bacterial diseases requires human epidemiologic studies with the 
appropriate bacteria and human sera. Our data suggest that such investigations may 
be fruitful. 
Summary 
In cooperation with human heat-inactivated antisera from adults immunized with 
group C meningococcal polysaccharide, normal human peripheral blood mononuclear 
cells significantly decreased the viability of group C  meningococci (Mgc) in vitro. K 
lymphocytes (Null cells) and monocytes, (but not T  or B lymphocytes) were capable 
of effecting antibody-dependent cell-mediated  (ADC)  antibacterial  activity in  this 
system. The degree to which meningococcal viability was decreased was a function of 
the length of the test incubation, the concentration of effector cells, and the amount 
of antiserum used in the assay. When specific antibodies directed against  Mgc were 
adsorbed from the antiserum, cell-mediated antibacterial activity was abolished. ADC 136  ANTIBACTERIAL ACTIVITY OF LYMPHOCYTES  AND MONOCYTES 
antibacterial activity was also abrogated by performing the assay at 4°C or by heating 
effector  cells to  46°C  for  15  min  before  the  assay.  Similarities between  this  ADC 
antibacterial system and previously described ADCC  assays are discussed. The data 
suggest that  K  cells (as well as monocytes)  may play a  role in host immune defense 
against pathogenic bacteria. 
We thank Dr. Samuel B. Formal for his help in reviewing this manuscript, and Ms. Jean Guidas 
and Ms. Lydia Scarlis for secretarial help. 
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